Calcium antagonist added to angiotensin receptor blocker: A recipe for reducing blood pressure variability?: Evidence from day-by-day home blood pressure monitoring

Hypertension

Volumn 59, Issue 6, 2012, Pages 1091-1093

  Parati, Gianfranco ^a,b   Bilo, Grzegorz ^a  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZELNIDIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN;

ADD ON THERAPY; ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; BLOOD PRESSURE FLUCTUATION; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CAROTID ARTERY PULSE; FOLLOW UP; HEART RATE; HUMAN; HYPERTENSION; NONHUMAN; NOTE; PRIORITY JOURNAL; TREATMENT RESPONSE;

AZETIDINECARBOXYLIC ACID; BLOOD PRESSURE; DIHYDROPYRIDINES; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; IMIDAZOLES; MALE; TETRAZOLES;

EID: 84861531436     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.193037     Document Type: Note

References (10)

1. Parati G, Faini A, Valentini M. Blood pressure variability: its measurement and significance in hypertension. Curr Hypertens Rep. 2006;8: 199-204.
2. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens. 1987;5:93-98.
3. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895-905.
4. Kikuya M, Ohkubo T, Metoki H, Asayama K, Hara A, Obara T, Inoue R, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama Study. Hypertension. 2008;52:1045-1050.
5. Liu JG, Xu LP, Chu ZX, Miao CY, Su DF. Contribution of blood pressure variability to the effect of nitrendipine on end-organ damage in spontaneously hypertensive rats. J Hypertens. 2003;21:1961-1967.
6. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive- drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and metaanalysis. Lancet. 2010;375:906-915.
7. Matsui Y, O'Rourke MF, Hoshide S, Ishikawa J, Shimada K, Kario K. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study. Hypertension. 2012;59;1132-1138.
8. Mancia G, Parati G, Pomidossi G, Casadei R, Di Rienzo M, Zanchetti A. Arterial baroreflexes and blood pressure and heart rate variabilities in humans. Hypertension. 1986;8:147-153.
9. Modesti PA, Morabito M, Bertolozzi I, Massetti L, Panci G, Lumachi C, Giglio A, Bilo G, Caldara G, Lonati L, Orlandino S, Maracchi G, Mancia G, Gensini GF, Parati G. Weather related changes in 24-hour blood pressure profile: effects of age and implications for hypertension management. Hypertension. 2006;47:155-161.
10. Frattola A, Parati G, Castiglioni P, Paleari F, Ulian L, Rovaris G, Mauri G, Di Rienzo M, Mancia G. Lacidipine and blood pressure variability in diabetic hypertensive patients. Hypertension. 2000;36:622-628.